Taddese Menassie — SEC insider filings
SEC reporting owner CIK 1848805. 10 insider filings on record with FilingPulse; latest filed 2026-11-04.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2021-03-04 to 2026-11-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 8,813 shares, $106,406 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 35.
- Largest priced transaction: sale of 8,813 shares @ $12.07 ($106,406) in Viatris Inc, filed 2022-05-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Viatris Inc (VTRS) | See Remarks | 8 | — | 1 leg · 8,813 sh · $106,406 | 33 |
| Xeris Biopharma Holdings, Inc. (XERS) | Director | 2 | — | — | 2 |
Insider filings — Taddese Menassie
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-04 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Grant/award (A): 22,365 @ $0 · Grant/award (A): 31,499 (derivative) @ $10.17 | EDGAR |
| 2026-11-04 | 3 | Xeris Biopharma Holdings, Inc. (XERS) | Holdings only — no transactions reported | EDGAR |
| 2022-05-27 | 4 | Viatris Inc (VTRS) | Sale (S): 8,813 @ $12.07 | EDGAR |
| 2022-03-23 | 4 | Viatris Inc (VTRS) | Option exercise (M): 80 @ $0 · Tax withholding (F): 34 @ $10.39 · Grant/award (A): 79.86 (derivative) @ $0 · Option exercise (M): 79.86 (derivative) @ $0 · Grant/award (A): 177.35 (derivative) @ $0 · Grant/award (A): 352.59 (derivative) @ $0 · +1 more | EDGAR |
| 2022-03-04 | 4 | Viatris Inc (VTRS) | Option exercise (M): 7,138 @ $0 · Tax withholding (F): 2,994 @ $10.48 · Option exercise (M): 171 @ $0 · Tax withholding (F): 73 @ $10.48 · Option exercise (M): 7,138 (derivative) @ $0 · Option exercise (M): 170.76 (derivative) @ $0 · +1 more | EDGAR |
| 2022-03-02 | 4 | Viatris Inc (VTRS) | Option exercise (M): 6,752 @ $0 · Tax withholding (F): 3,218 @ $11.01 · Option exercise (M): 162 @ $0 · Tax withholding (F): 78 @ $11.01 · Option exercise (M): 6,752 (derivative) @ $0 · Option exercise (M): 161.36 (derivative) @ $0 | EDGAR |
| 2021-12-23 | 4 | Viatris Inc (VTRS) | Grant/award (A): 57.92 (derivative) @ $0 · Grant/award (A): 128.64 (derivative) @ $0 · Grant/award (A): 255.76 (derivative) @ $0 · Grant/award (A): 183.69 (derivative) @ $0 | EDGAR |
| 2021-09-24 | 4 | Viatris Inc (VTRS) | Grant/award (A): 54.64 (derivative) @ $0 · Grant/award (A): 121.37 (derivative) @ $0 · Grant/award (A): 241.30 (derivative) @ $0 · Grant/award (A): 173.31 (derivative) @ $0 | EDGAR |
| 2021-06-23 | 4 | Viatris Inc (VTRS) | Grant/award (A): 48.80 (derivative) @ $0 · Grant/award (A): 108.39 (derivative) @ $0 · Grant/award (A): 215.49 (derivative) @ $0 · Grant/award (A): 154.77 (derivative) @ $0 | EDGAR |
| 2021-03-04 | 4 | Viatris Inc (VTRS) | Grant/award (A): 21,414 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-03-03 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1848805 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs